Last reviewed: June 17, 2026

Last updated: June 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active compound in Ozempic and Wegovy, works through a carefully structured dosing protocol that begins at 0.25 mg and may increase based on your tolerance and response. Understanding how semaglutide dosing progresses helps patients set realistic expectations and work effectively with their healthcare team. PlexusDx provides access to compounded semaglutide injections from licensed 503A pharmacies across all 50 states, with straightforward pricing that supports patients at every dose level.

Understanding Semaglutide Dose Progression and Timeline

Semaglutide follows a structured escalation schedule designed to help your body adjust gradually to the medication. Most patients begin at 0.25 mg once weekly, then advance to 0.5 mg in week five, then 1.0 mg in week nine, and potentially 1.7 mg or 2.4 mg in later weeks depending on clinical response and tolerability. This gradual approach reduces nausea and gastrointestinal side effects while allowing your GLP-1 receptors to respond optimally to the therapy. The entire titration period typically spans 16 to 20 weeks, though individual timelines vary based on how your body responds.

The dose your healthcare provider recommends depends on your starting weight, metabolic health, prior medication history, and how you tolerate each step. Some patients reach their target dose in 12 weeks, while others benefit from a slower progression over 24 weeks or longer. PlexusDx works with licensed prescribers who can adjust your dose schedule to match your individual tolerance and goals, ensuring you receive the most effective and comfortable treatment path.

Maximum Semaglutide Doses and Clinical Evidence

The highest FDA-discussed dose for semaglutide in weight-management trials is 2.4 mg weekly, the dose studied in the STEP clinical trial program that showed average weight loss of 14-17% of baseline body weight. However, effective doses can range from 0.5 mg to 2.4 mg weekly depending on your physiology and treatment goals. Some patients achieve meaningful weight loss and metabolic improvement at 1.0 or 1.7 mg, while others require the higher 2.4 mg dose to maximize their response. Your prescriber evaluates your progress at each dose level before recommending an increase.

Clinical data shows that dose escalation matters less than individual responsiveness—some patients lose as much weight at 1.0 mg as others do at 2.4 mg because of genetic and metabolic differences. PlexusDx Precision Peptide Genetic Testing can identify variants in your GLP1R and GIPR genes that predict your likely dose responsiveness, helping your prescriber choose a personalized starting strategy rather than guessing.

Why Your Dose May Change and How PlexusDx Supports Adjustments

Your semaglutide dose may increase for several reasons: insufficient appetite suppression, plateaued weight loss after 4-8 weeks at a stable dose, or improved tolerance allowing progression to the next level. Your prescriber monitors your progress through regular check-ins and may recommend staying at your current dose longer, increasing gradually, or occasionally stepping back if side effects become bothersome. PlexusDx offers injectable semaglutide starting at $149 per month regardless of your dose level—whether you inject 0.25 mg or 2.4 mg weekly, your monthly cost remains the same, removing financial barriers to dose optimization.

Some patients require maintenance at a lower dose than traditional protocols suggest, especially if they achieve their weight-loss target or experience persistent side effects at higher levels. A healthcare provider working with PlexusDx can tailor a maintenance strategy that keeps you on your effective dose indefinitely, adjusting only if your response changes over time or your health goals shift.

Compounded Semaglutide vs. Brand-Name Options: Dosing Flexibility

PlexusDx compounded semaglutide injections from licensed 503A pharmacies offer the same active pharmaceutical ingredient as brand-name Ozempic and Wegovy, with flexibility to dose at any interval your prescriber determines safe and effective. Brand-name products come in pre-filled pens at fixed weekly doses, while compounded injectable semaglutide can be drawn to precise amounts and injected according to your personalized schedule. This flexibility becomes valuable if you need a slower titration, a maintenance dose between standard increments, or a dose adjustment between regularly scheduled appointments.

PlexusDx eliminates insurance requirements and membership fees, making compounded semaglutide accessible and affordable across all 50 states. HSA and FSA accounts cover compounded semaglutide from PlexusDx, and the flat pricing model—starting at $149 monthly—means you pay the same whether you increase your dose or reduce it for side-effect management. Licensed compounders ensure sterility, potency, and consistency, with the same quality standards that govern pharmacy practice nationwide.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is a typical starting semaglutide dose?

Most patients begin at 0.25 mg injected subcutaneously once weekly for four weeks, then escalate to 0.5 mg in week five. This low starting dose allows your body to acclimate and reduces the risk of nausea or other gastrointestinal side effects. PlexusDx compounded semaglutide supports this standard titration schedule and can accommodate faster or slower progression based on your prescriber's recommendation.

Can I stay on a low semaglutide dose and still lose weight?

Yes—clinical evidence and real-world experience show that many patients achieve significant weight loss at doses of 0.5 mg to 1.0 mg weekly. Your individual genetics, metabolism, and baseline health status determine your optimal dose, which may be lower than the maximum 2.4 mg studied in trials. PlexusDx's Precision Peptide Genetic Test analyzes your GLP1R and GIPR variants to help your prescriber predict whether you'll respond robustly at a lower dose or may need higher escalation.

How much does semaglutide cost if I increase my dose?

PlexusDx compounded semaglutide injections are priced at a flat rate of $149 per month—your cost does not change if your prescriber increases your dose from 0.5 mg to 2.4 mg. This transparent pricing model ensures you can optimize your dose for best results without worrying about escalating medication costs. PlexusDx serves all 50 states, requires no insurance or membership, and accepts HSA and FSA payments.

What happens if semaglutide side effects are too strong at my current dose?

Your prescriber can reduce your dose, extend the time between dose increases, or temporarily hold your current dose while side effects settle. Nausea, vomiting, and appetite loss typically improve within days to weeks as your body adjusts, but persistent symptoms may warrant a slower titration schedule. PlexusDx works with licensed prescribers who can modify your dosing plan without penalty or additional cost, keeping you comfortable while pursuing your weight-loss goals.

How does the Precision Peptide Genetic Test help with semaglutide dosing?

PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first treatment month) examines 14 metabolic pathways including key variants like GLP1R rs6923761 and GIPR rs1800437 that influence how strongly you respond to semaglutide. Patients with high-response variants may see meaningful results at lower doses, while those with lower-response patterns may need earlier escalation to 1.7 or 2.4 mg. This genetic insight helps your prescriber personalize your dose strategy from the start, potentially saving time and improving your treatment success rate.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves